Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent Cancer

Hepatitis B virus-related hepatocellular carcinoma recurrence after liver transplantation (LT) is notoriously difficult to manage and fatal. As a therapeutic option, adoptive cell therapy with HBV-specific TCR-redirected T cells could be employed to target and control relapses in these patients. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafezi, Morteza, Tan, Anthony, Bertoletti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393584/
https://www.ncbi.nlm.nih.gov/pubmed/34440630
http://dx.doi.org/10.3390/cells10081861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393584/
https://www.ncbi.nlm.nih.gov/pubmed/34440630
http://dx.doi.org/10.3390/cells10081861

Ejemplares similares